Tina Ventura | IR |
Tim Walbert | Chairman, President and CEO |
Paul Hoelscher | EVP and CFO |
Shao-Lee Lin | EVP, Head of Research and Development and Chief Scientific Officer |
Bob Carey | EVP and Chief Business Officer |
Vikram Karnani | EVP and Chief Commercial Officer |
Annabel Samimy | Stifel |
Chris Staral | Goldman Sachs |
David Amsellem | Piper Jaffray |
Louise Chen | Cantor Fitzgerald |
Ken Cacciatore | Cowen and Company |
Irina Koffler | Mizuho |
Gary Nachman | BMO Capital Markets |
David Risinger | Morgan Stanley |
Good morning and thank you for standing by. Welcome to the Horizon Pharma plc Third Quarter 2018 Earnings Conference Call.
As a reminder, today’s conference call is being recorded. I would now like to introduce Ms. Tina Ventura, Senior Vice President of Investor Relations.